| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1001895237 |
| P356 | DOI | 10.1385/IR:32:1-3:015 |
| P698 | PubMed publication ID | 16106056 |
| P2093 | author name string | Robert H Arch | |
| P2860 | cites work | A physical and functional map of the human TNF-alpha/NF-kappa B signal transduction pathway | Q21735927 |
| Prevention of constitutive TNF receptor 1 signaling by silencer of death domains | Q22008692 | ||
| Identification of a new member of the tumor necrosis factor family and its receptor, a human ortholog of mouse GITR | Q22009014 | ||
| Fas preassociation required for apoptosis signaling and dominant inhibition by pathogenic mutations | Q22254363 | ||
| A novel mechanism of TRAF signaling revealed by structural and functional analyses of the TRADD-TRAF2 interaction | Q22254604 | ||
| Activation of human CD4+ cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype | Q24293121 | ||
| The human OX40 homolog: cDNA structure, expression and chromosomal assignment of the ACT35 antigen | Q24305105 | ||
| Anatomy of TRAF2. Distinct domains for nuclear factor-kappaB activation and association with tumor necrosis factor signaling proteins | Q24311703 | ||
| TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways | Q24317441 | ||
| A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor | Q24318280 | ||
| Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease | Q24324634 | ||
| 4-1BB and Ox40 Are Members of a Tumor Necrosis Factor (TNF)-Nerve Growth Factor Receptor Subfamily That Bind TNF Receptor-Associated Factors and Activate Nuclear Factor κB | Q24533857 | ||
| Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1 | Q24564855 | ||
| CD40 ligand-dependent T cell activation: requirement of B7-CD28 signaling through CD40. | Q45878144 | ||
| Regulatory CD4 T cells control the size of the peripheral activated/memory CD4 T cell compartment | Q47243986 | ||
| Human CD4+CD25+ regulatory T cells share equally complex and comparable repertoires with CD4+CD25- counterparts | Q47644330 | ||
| Induction of foxP3+ regulatory T cells in the periphery of T cell receptor transgenic mice tolerized to transplants | Q47644499 | ||
| Apoptosis signaling by death receptors. | Q47751546 | ||
| Regulation of murine inflammatory bowel disease by CD25+ and CD25- CD4+ glucocorticoid-induced TNF receptor family-related gene+ regulatory T cells | Q47777710 | ||
| Functional impairment of CD8(+) T cells by regulatory T cells during persistent retroviral infection | Q47926468 | ||
| Distinct roles for the OX40-OX40 ligand interaction in regulatory and nonregulatory T cells | Q47991866 | ||
| Regulatory CD4 T cells: expression of IL-2R alpha chain, resistance to clonal deletion and IL-2 dependency | Q47992795 | ||
| Increased expression and activation of CD30 induce apoptosis in human blood eosinophils | Q51643286 | ||
| Targeted disruption of TRAF3 leads to postnatal lethality and defective T-dependent immune responses | Q52522634 | ||
| CD40 ligation releases immature dendritic cells from the control of regulatory CD4+CD25+ T cells. | Q52552727 | ||
| Apoptosis and autoimmune disease | Q52568297 | ||
| NOD mice have a generalized defect in their response to transplantation tolerance induction | Q54095945 | ||
| Spontaneous thyroiditis in thymectomized and irradiated Wistar rats | Q54626352 | ||
| Early Events in Peripheral Regulatory T Cell Induction via the Nasal Mucosa | Q56903755 | ||
| Cutting edge: lymphoproliferative disease in the absence of CTLA-4 is not T cell autonomous | Q56906844 | ||
| Impaired Negative Selection of T Cells in Hodgkin's Disease Antigen CD30–Deficient Mice | Q57185434 | ||
| Increased T cell autoreactivity in the absence of CD40-CD40 ligand interactions: a role of CD40 in regulatory T cell development | Q73311881 | ||
| Nasal tolerance induces antigen-specific CD4+CD25- regulatory T cells that can transfer their regulatory capacity to naive CD4+ T cells | Q73401157 | ||
| Prolonged survival of mouse skin allografts in recipients treated with donor splenocytes and antibody to CD40 ligand | Q73585351 | ||
| Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide | Q73688337 | ||
| Expression of the costimulatory receptor CD30 is regulated by both CD28 and cytokines | Q74303620 | ||
| TRAF1 is a negative regulator of TNF signaling. enhanced TNF signaling in TRAF1-deficient mice | Q74840082 | ||
| Control of intestinal inflammation by regulatory T cells | Q77291202 | ||
| Mechanisms of CD95 (APO-1/Fas)-mediated apoptosis | Q77485539 | ||
| Pancreatic lymph node-derived CD4(+)CD25(+) Treg cells: highly potent regulators of diabetes that require TRANCE-RANK signals | Q77704341 | ||
| CD30 overexpression enhances negative selection in the thymus and mediates programmed cell death via a Bcl-2-sensitive pathway | Q77929168 | ||
| Expression of CD30 and Ox40 on T lymphocyte subsets is controlled by distinct regulatory mechanisms | Q79317441 | ||
| The 4-1BB costimulation augments the proliferation of CD4+CD25+ regulatory T cells | Q80418671 | ||
| TGF-beta regulates in vivo expansion of Foxp3-expressing CD4+CD25+ regulatory T cells responsible for protection against diabetes | Q37358159 | ||
| Analysis of Autoimmunity through Experimental Models of Thyroiditis and Allergic Encephalomyelitis | Q40099202 | ||
| CD4+CD25+ regulatory T cells suppress allograft rejection mediated by memory CD8+ T cells via a CD30-dependent mechanism | Q40416864 | ||
| Targeted CTLA-4 engagement induces CD4+CD25+CTLA-4high T regulatory cells with target (allo)antigen specificity. | Q40528327 | ||
| Costimulation via glucocorticoid-induced TNF receptor in both conventional and CD25+ regulatory CD4+ T cells | Q40547487 | ||
| In vitro-expanded human CD4(+)CD25(+) T-regulatory cells can markedly inhibit allogeneic dendritic cell-stimulated MLR cultures | Q40576782 | ||
| Tumor antigens recognized by T lymphocytes | Q40661131 | ||
| Reactive oxygen species are downstream products of TRAF-mediated signal transduction | Q40780289 | ||
| Translocation of TRAF proteins regulates apoptotic threshold of cells | Q40873039 | ||
| Cellular interactions in thymocyte development. | Q41039662 | ||
| The shaping of the brain-specific T lymphocyte repertoire in the thymus. | Q41230479 | ||
| Tumor necrosis factor alpha-induced activation of c-jun N-terminal kinase is mediated by TRAF2. | Q41890014 | ||
| Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state | Q42466421 | ||
| Strong expression of CD134 (OX40), a member of the TNF receptor family, in a T helper 2-type cytokine environment | Q42539114 | ||
| Cutting edge: estrogen drives expansion of the CD4+CD25+ regulatory T cell compartment | Q45007526 | ||
| Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor | Q24597543 | ||
| Signaling by proinflammatory cytokines: oligomerization of TRAF2 and TRAF6 is sufficient for JNK and IKK activation and target gene induction via an amino-terminal effector domain | Q24604330 | ||
| Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation | Q24676080 | ||
| OX-22high CD4+ T cells induce wasting disease with multiple organ pathology: prevention by the OX-22low subset | Q24682576 | ||
| A new member of the tumor necrosis factor/nerve growth factor receptor family inhibits T cell receptor-induced apoptosis | Q24683805 | ||
| The structural basis for the recognition of diverse receptor sequences by TRAF2 | Q27619945 | ||
| Control of regulatory T cell development by the transcription factor Foxp3 | Q27860489 | ||
| Foxp3 programs the development and function of CD4+CD25+ regulatory T cells | Q27860714 | ||
| Mechanisms of caspase activation and inhibition during apoptosis | Q27919623 | ||
| Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases | Q28131652 | ||
| The TNF-receptor-associated factor family: scaffold molecules for cytokine receptors, kinases and their regulators | Q28198125 | ||
| The CD40/CD154 receptor/ligand dyad | Q28202756 | ||
| Apoptosis in the pathogenesis and treatment of disease | Q28235731 | ||
| TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling | Q28513445 | ||
| Mouse glucocorticoid-induced tumor necrosis factor receptor ligand is costimulatory for T cells | Q28513895 | ||
| Characterization of the MRC OX40 antigen of activated CD4 positive T lymphocytes--a molecule related to nerve growth factor receptor | Q28576279 | ||
| Targeted disruption of Traf5 gene causes defects in CD40- and CD27-mediated lymphocyte activation | Q28584897 | ||
| Interleukin-2 receptor α chain regulates the size and content of the peripheral lymphoid compartment | Q28587823 | ||
| Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene | Q28593669 | ||
| Tumor necrosis factor receptor-associated factors (TRAFs)—a family of adapter proteins that regulates life and death | Q28609905 | ||
| TRAF2-mediated activation of NF-kappa B by TNF receptor 2 and CD40 | Q28610812 | ||
| An essential role for NF-kappaB in preventing TNF-alpha-induced cell death | Q29614707 | ||
| AP-1 in cell proliferation and survival | Q29615217 | ||
| Early Lethality, Functional NF-κB Activation, and Increased Sensitivity to TNF-Induced Cell Death in TRAF2-Deficient Mice | Q29618716 | ||
| X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy | Q29619109 | ||
| NF-kappaB at the crossroads of life and death | Q29619302 | ||
| The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3 | Q29619324 | ||
| A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis | Q29619339 | ||
| Lymphocyte survival--the struggle against death | Q33804304 | ||
| Identification of a novel activation-inducible protein of the tumor necrosis factor receptor superfamily and its ligand | Q33853062 | ||
| Survival of mouse pancreatic islet allografts in recipients treated with allogeneic small lymphocytes and antibody to CD40 ligand. | Q33853487 | ||
| An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation | Q33876035 | ||
| A domain in TNF receptors that mediates ligand-independent receptor assembly and signaling | Q33907802 | ||
| Regulatory T cells: key controllers of immunologic self-tolerance | Q33941140 | ||
| Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance | Q34111451 | ||
| CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor | Q34116317 | ||
| Role of GITR in activation response of T lymphocytes. | Q34133855 | ||
| An overview of the immune system | Q34280088 | ||
| Generalized autoimmune disease in interleukin-2-deficient mice is triggered by an uncontrolled activation and proliferation of CD4+ T cells | Q34289467 | ||
| GITR, a member of the TNF receptor superfamily, is costimulatory to mouse T lymphocyte subpopulations | Q34302055 | ||
| IL-10-secreting regulatory T cells do not express Foxp3 but have comparable regulatory function to naturally occurring CD4+CD25+ regulatory T cells | Q34318928 | ||
| Signal transduction by tumor necrosis factor and its relatives | Q34341941 | ||
| Thymus and autoimmunity: production of CD25+CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance | Q34503328 | ||
| Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. | Q34509694 | ||
| All TRAFs are not created equal: common and distinct molecular mechanisms of TRAF-mediated signal transduction | Q34543653 | ||
| In vivo instruction of suppressor commitment in naive T cells | Q34548023 | ||
| Organ-specific autoimmune diseases induced in mice by elimination of T cell subset. I. Evidence for the active participation of T cells in natural self-tolerance; deficit of a T cell subset as a possible cause of autoimmune disease | Q34693075 | ||
| The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells | Q34693140 | ||
| Thymus and Reproduction: Sex-Linked Dysgenesia of the Gonad after Neonatal Thymectomy in Mice | Q34705919 | ||
| Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis | Q34719541 | ||
| Targeting death and decoy receptors of the tumour-necrosis factor superfamily | Q34791120 | ||
| The TNF-TNF receptor system | Q35009296 | ||
| Thymic selection revisited: how essential is it? | Q35076679 | ||
| The signaling adaptors and pathways activated by TNF superfamily | Q35145613 | ||
| Biology of the TRANCE axis | Q35145622 | ||
| Control of autoimmunity by naturally arising regulatory CD4+ T cells | Q35623006 | ||
| Specialization in tolerance: innate CD(4+)CD(25+) versus acquired TR1 and TH3 regulatory T cells | Q35630644 | ||
| Development and function of CD25+CD4+ regulatory T cells | Q35692191 | ||
| Antigen-induced regulatory T cells | Q35693709 | ||
| X-linked lymphoreticular disease in the scurfy (sf) mutant mouse | Q35831357 | ||
| Major histocompatibility complex class II-positive cortical epithelium mediates the selection of CD4(+)25(+) immunoregulatory T cells | Q36369536 | ||
| In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. | Q36370315 | ||
| CD4+CD25+ T regulatory cells dependent on ICOS promote regulation of effector cells in the prediabetic lesion | Q36399063 | ||
| CD25(+)CD4(+) regulatory T cells from the peripheral blood of asymptomatic HIV-infected individuals regulate CD4(+) and CD8(+) HIV-specific T cell immune responses in vitro and are associated with favorable clinical markers of disease status | Q36399748 | ||
| Role for CD4(+) CD25(+) regulatory T cells in reactivation of persistent leishmaniasis and control of concomitant immunity | Q36399862 | ||
| GITR activation induces an opposite effect on alloreactive CD4(+) and CD8(+) T cells in graft-versus-host disease | Q36399867 | ||
| Cooperative roles of CTLA-4 and regulatory T cells in tolerance to an islet cell antigen | Q36402656 | ||
| Engagement of B7 on effector T cells by regulatory T cells prevents autoimmune disease | Q36672085 | ||
| Cloning of mouse Ox40: a T cell activation marker that may mediate T-B cell interactions | Q36754519 | ||
| P433 | issue | 1-3 | |
| P304 | page(s) | 15-29 | |
| P577 | publication date | 2005-01-01 | |
| P13046 | publication type of scholarly work | review article | Q7318358 |
| P1433 | published in | Immunologic Research | Q15754981 |
| P1476 | title | Function of tumor necrosis factor receptor family members on regulatory T-cells | |
| P478 | volume | 32 |
Search more.